4 NHS eligibility criteria: BMI 35 with weight-related health conditions, or BMI 30 in exceptional circumstances Referral to a specialist NHS weight management service Evidence of previous weight loss attempts NHS prescription cost: Standard prescription charge (9.90 as of 2025, free in Scotland, Wales, and Northern Ireland) Private access Private providers accept broader eligibility: BMI 30, or BMI 27 with a weight-related health condition Most people currently access Wegovy privately because NHS criteria are restrictive and specialist weight management service capacity is limited
Assistance Programs: We actively work with patients to identify eligibility for manufacturer coupons, savings programs, or patient assistance initiatives that may reduce your out-of-pocket expenses
GLP-1 medications support meaningful weight loss when paired with provider-guided dosing, adherence, and behavior change
Notably, there was no discernible difference in serum cholesterol levels between the standard treatment group (10 mg/kg Ulipristal acetate) and 50 mg/kg and 100 mg/kg groups
It hard to seek out educated individuals on this subject, however you sound like you realize what you are speaking about
Wegovy 7.2mg is only available if: you have been following a Wegovy treatment plan for at least 20 weeks your BMI was 30 or above when you first started Wegovy (or over 27 with a weight-related health concern) a prescriber has approved this dose for you If you do not meet these requirements, please start with the 0.25mg Wegovy FlexTouch Pen